Clinical trial
Tirzepatide Versus Positive Airway Pressure for the Treatment of Obstructive Sleep Apnoea: A Randomised Comparative Effectiveness Trial
NCT07846865 is registered in ClinicalTrials.gov with Woolcock Institute of Medical Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tirzepatide Versus Positive Airway Pressure for the Treatment of Obstructive Sleep Apnoea: A Randomised Comparative Effectiveness Trial
- Lead sponsor
- Woolcock Institute of Medical Research
- Phase
- Phase 2/3
- Overall status
- Not yet recruiting
- Start date
- October 1, 2026
- Completion date
- December 1, 2028
- Enrollment
- 256 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
obesity & overweight, sleep apnea syndrome, obstructive, sleep apnoea